Deep and quantitative top-down proteomics in clinical and translational research

Expert Review of Proteomics

Volumn 11, Issue 6, 2014, Pages 649-651

  Kelleher, Neil L ^a   Thomas, Paul M ^a   Ntai, Ioanna ^a   Compton, Philip D ^a   Leduc, Richard D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

clinical; proteomics; quantitative; top down; translational

Indexed keywords

PROTEIN; BIOLOGICAL MARKER; PROTEOME;

ALTERNATIVE RNA SPLICING; CLINICAL RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN GENOME; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; TRANSLATIONAL RESEARCH; MEDICAL RESEARCH; METABOLISM; PROCEDURES; PROTEIN PROCESSING;

BIOMARKERS; BIOMEDICAL RESEARCH; HUMANS; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOLYSIS; PROTEOME; PROTEOMICS;

EID: 84910673767     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2014.976559     Document Type: Review

References (21)

1. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 2009;3(1): 33-44
2. Walther TC, Mann M. Mass spectrometry-based proteomics in cell biology. J Cell Biol 2010;190(4):491-500
3. LeDuc RD, Fellers RT, Early BP, et al. The C-score: a Bayesian framework to sharply improve proteoform scoring in high-throughput top down proteomics. J Proteome Res 2014;13(7):3231-40
4. Smith LM, Kelleher NL. Proteomics, C.T. D., Proteoform: a single term describing protein complexity. Nat Methods 2013; 10(3):186-7
5. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000; 405(6788):837-46
6. Shteynberg D, Deutsch EW, Lam H, et al. iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates. Mol Cell Proteomics 2011; 10(12):M111.007690
7. Siuti N, Kelleher NL. Decoding protein modifications using top-down mass spectrometry. Nat Methods 2007;4(10): 817-21
8. Savaryn JP, Catherman AD, Thomas PM, et al. The emergence of top-down proteomics in clinical research. Genome Med 2013;5:53
9. Li XJ, Hayward C, Fong PY, et al. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med 2013;5(207): 207ra142
10. Khan Z, Ford MJ, Cusanovich DA, et al. Primate transcript and protein expression levels evolve under compensatory selection pressures. Science 2013;342(6162):1100-4
11. Ntai I, Kim K, Fellers RT, et al. Applying label-free quantitation to top down proteomics. Anal Chem 2014;86(10): 4961-8
12. Catherman AD, Durbin KR, Ahlf DR, et al. Large-scale top-down proteomics of the human proteome: membrane proteins, mitochondria, and senescence. Mol Cell Proteomics 2013;12(12):3465-73
13. Wu S, Brown JN, Tolic N, et al. Quantitative analysis of human salivary gland-derived intact proteome using top-down mass spectrometry. Proteomics 2014;14(10):1211-22
14. Kellie JF, Higgs RE, Ryder JW, et al. Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry. Sci Rep 2014;4:5797
15. Barnidge DR, Dasari S, Botz CM, et al. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy. J Proteome Res 2014;13(3):1419-27
16. Iavarone F, Melis M, Platania G, et al. Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics. J Proteomics 2014;103:15-22
17. Edwards RL, Griffiths P, Bunch J, Cooper HJ. Compound heterozygotes and beta-thalassemia: top-down mass spectrometry for detection of hemoglobinopathies. Proteomics 2014; 14(10):1232-8
18. 510(k) Substantial equivalence determination decision summary. 2014. www.accessdata.fda.gov/cdrh-docs/reviews/K130831.pdf Last accessed 10 August 2014]
19. Amyloidosis, transthyretin-associated familial, reflex. Blood 2014.www. mayomedicallaboratories.com/test-catalog/Overview/83674 [Last accessed 10 August 2014]
20. Thalassemia and hemoglobinopathy evaluation. 2014.www. mayomedicallaboratories.com/test-catalog/Overview/84158 [Last accessed 10 August 2014]
21. IGF-I, LC/MS. 2014.www.questdiagnostics. com/testcenter/TestDetail.action?ntc=16293 [Last accessed 10 August 2014]